Skip to main content
logo
Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
86.82
-1.73 (-1.95%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States Revenue
4.69B4.67B4.56B
International Revenue
3.57B3.66B3.70B
Revenue (Other)
1.00M--
Revenue (Total)
8.26B8.33B8.25B

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
MedSurg Revenue
4.89B4.82B4.64B
Dental Solutions Revenue
1.38B1.35B1.30B
Health Information Systems Revenue
1.37B1.36B1.31B
Purification and Filtration Revenue
-497.00M709.00M
Corporate and Unallocated Revenue
365.00M302.00M306.00M
Revenue (Other)
255.00M-1.00M
Revenue (Total)
8.26B8.33B8.25B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue
6.27B6.35B6.35B
Software and Rental Revenue
2.00B1.98B1.91B
Revenue (Total)
8.26B8.33B8.25B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
MedSurg Operating Income
765.00M810.00M887.00M
Dental Solutions Operating Income
354.00M346.00M350.00M
Health Information Systems Operating Income
517.00M496.00M431.00M
Purification and Filtration Operating Income
-96.00M74.00M
Corporate Operating Income
399.00M432.00M-706.00M
Operating Income (Other)
74.00M1.00M-
Operating Income (Total)
2.11B2.18B1.04B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Organic Sales Growth
3.30%1.20%